Crispr Therapeutics (CRSP) Experts Views (BUY SELL) [2025] (CRSP) share price target ["experts views"] BUY/SELL -NASDAQ stock exchange

Crispr Therapeutics CRSP Experts view BUY SELL, share price targets for short, mid, long term 2025 NASDAQ stock exchange

NASDAQ stock CRSP Crispr Therapeutics experts views & buy sell levels signals are here. Crispr Therapeutics forecast & share price targets are here or Crispr Therapeutics share price targets and CRSP Crispr Therapeutics tomorrow's movements predictions are here or Announcements & NEWS by Crispr Therapeutics

Stock listed under Health Care

Crispr Therapeutics share price opened at: 37.99
Crispr Therapeutics share price closed at: 36.99
Crispr Therapeutics share price made a High of: 38.20
Crispr Therapeutics share price made a low of: 36.93

Detailed analysis of what to do in Intraday & BTST tips for Crispr Therapeutics are here
52 week High of Crispr Therapeutics: 91.10
52 week Low of Crispr Therapeutics: 36.52
CRSP is trading in the lower range of yearly prices.

Went as high as 55.88 in the last three months (quarter)
Went as low as 36.52 in the last three months (quarter)
CRSP is trading in the lower range of the quarterly prices.

The session was a bearish session and prices moved within a range of 36.93 and 38.20, with a volume of 0.67% compared to average volume that Crispr Therapeutics normally has.

The NASDAQ share CRSP Crispr Therapeutics does not have a defined movement as of now. Keep reading experts views on Crispr Therapeutics below for shortterm to longterm CRSP share prices targets and buy sell signals, points & levels.

NASDAQ CRSP Experts Views Crispr Therapeutics Buy Sell Signals

The share prices have been falling shortly. An initial buy or sell signal has not been generated yet. However, if a BUY/SELL signal is mentioned below then you can choose to take a trade with a strict stoploss.

NASDAQ CRSP Experts Views Crispr Therapeutics MACD Convergence Divergence

Crispr Therapeutics fast MACD line is below the slow signal MACD line, and in dead cross zone, negative zone

Both the lines are diverging, going away from each other, with a difference of 0.64
The stock might soon become over-sold and might reverse its trend from there on. However, its still far from a BUY signal. Bookmark this page & recheck again.

NASDAQ CRSP Crispr Therapeutics experts views on Support & Resistance

These support and resistance levels of CRSP are derived based on analysis of an entire years daily closing prices. These are all extremely strong levels to watch in Crispr Therapeutics

Levels to watch:

Crispr Therapeutics has strong support or resistance at 39, 45, 51, 57, 65
The current share price is 36.99

Crispr Therapeutics CRSP share price targets

Levels of 40.83, 42.03, 43.07, 44.39, 47.71 are share price targets for Crispr Therapeutics CRSP Click here for weekly and monthly share price targets

Experts also view these below mentioned levels as important because Crispr Therapeutics has been reversing its trend at these levels. These levels below are derived by analysing one year charts of Crispr Therapeutics

Important support & resistance levels of CRSP are 39.82, 44.39, 47.71, 58.46, 67.6, 83.7. Experts view is that the stock of Crispr Therapeutics might change its trend at one of these levels.

Whether these targets will be achieved or not will depend on the trend of Crispr Therapeutics. See the Convergence & Divergence section above to understand the trend of NASDAQ share Crispr Therapeutics. You can also check Future Forecast & Targets for Crispr Therapeutics or Crispr Therapeutics share price targets or Tomorrow's predictions for Crispr Therapeutics

Share on: WhatsApp @Hash Facebook Tweet

NASDAQ share CRSP experts views on candles stick analysis of Crispr Therapeutics

Daily candle stick experts view of NASDAQ share Crispr Therapeutics

Latest Crispr Therapeutics candle stick is a bearish candle, with a length of 2.7%
High made is about 0.55% above the opening.
Crispr Therapeutics share price high is about -80% of the candle stick body.
Crispr Therapeutics share price Low made is about 0.16% below the closing.
Low share price is about -94% of the candle stick body.

Experts view is that the stock showed immediate selloff from higher levels in this session.

Previous candle stick is a bearish candle, with a length of 4.13%

Two candles back candle stick is a bullish candle, with a length of 1.48%

Weekly candle stick experts view of NASDAQ share Crispr Therapeutics

Latest Crispr Therapeutics candle stick is a bearish candle, with a length of 13.54%
High made is about 1.71% above the opening.
Crispr Therapeutics share price high is about -87% of the candle stick body.
Crispr Therapeutics share price Low made is about 0.16% below the closing.
Low share price is about -99% of the candle stick body.

Experts view is that the stock showed immediate selloff from higher levels in this session.

Previous candle stick is a bearish candle, with a length of 1.75%

two candles back candle stick is a bearish candle, with a length of 6.05%

Monthly candle stick experts view of NASDAQ share Crispr Therapeutics

Latest Crispr Therapeutics candle stick is a bearish candle, with a length of 22.09%
High made is about 2.02% above the opening.
Crispr Therapeutics share price high is about -91% of the candle stick body.
Crispr Therapeutics share price Low made is about 0.16% below the closing.
Low share price is about -99% of the candle stick body.

Experts view is that the stock showed immediate selloff from higher levels in this session.

Previous candle stick is a bullish candle, with a length of 9.28%

Two candles back candle stick is a bullish candle, with a length of 4.47%

View charts of Crispr Therapeutics below

Crispr Therapeutics share price targets or Crispr Therapeutics Support & Resistance Levels

Daily Charts of CRSP , Daily candle stick charts of CRSP, Weekly charts of CRSP , Monthly Charts of CRSP , Moving Averages charts of CRSP , MACD charts of CRSP , or Technical analysis Reports of CRSP , or simply read Tomorrow's predictions of CRSP and Future Forecast & share price targets of Crispr Therapeutics or Crispr Therapeutics share price targets